G

Glenn J. Hanna

Dana-Farber Cancer Institute

ORCID: 0000-0002-9969-2523

Publishes on Head and Neck Cancer Studies, Salivary Gland Tumors Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. 518 papers and 7.5k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

518Publications

7.5kTotal Citations

First publication: 2011First senior author: 2018

Head and Neck Cancer Studies Salivary Gland Tumors Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics

Top publicationsby citations

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

Diana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018

Cited by 701

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Douglas R. Adkins, Katie M. Campbell et al.|Clinical Cancer Research|2020

Cited by 368

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Robert I. Haddad, Glenn J. Hanna et al.|JAMA Oncology|2020

Cited by 350

Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer

Nikhil Wagle, Jochen H. Lorch, Brian C. Grabiner et al.|New England Journal of Medicine|2014

Cited by 327

Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma

Yvonne Y. Li, Peter S. Hammerman, Glenn J. Hanna et al.|Clinical Cancer Research|2015

Cited by 282